Malaria vaccination and rebound malaria [PDF]
The Lancet Infectious Diseases, 2019 Dicko, Alassane, Greenwood, Brian
openaire +2 more sources
Immune mechanisms targeting malaria transmission: opportunities for vaccine development
Expert Review of VaccinesIntroduction Malaria continues to remain a major global health problem with nearly a quarter of a billion clinical cases and more than 600,000 deaths in 2022.
Geetha P. Bansal, Nirbhay Kumar
doaj +1 more source
Therapeutic Opportunities in Infectious Diseases: Highlights from the Society of Medicines Research Symposium, held on March 14th 2013 at the National Heart & Lung Institute, London, UK [PDF]
, 2013 Alderton, W K +3 more
core +1 more source
Malaria Vaccines: Progress to Date. [PDF]
BioDrugs, 2023 Stanisic DI, Good MF.
europepmc +1 more source
ELISPOT assay to measure antigen-specific murine CD8(+) T cell responses.
, 2001 The enzyme-linked immunospot technique (ELISPOT) relies on the visualization of cytokine secretion by individual T cells following in vitro stimulation with antigen. This assay has been developed and standardized for the quantitative detection of antigen-
Carvalho, LH, Hafalla, JC, Zavala, F
core +1 more source
The hope for neglected diseases: R&D incentives [PDF]
Neglected diseases are neglected because they cannot generate enough return on R&D to pharmaceutical firms. This paper analyzes and compares existing proposals for public intervention in R&D for neglected diseases.
Brigitte Granville, Eshref Trushin
core
Innovation With Impact: Financing 21st Century Development [PDF]
, 2011 Leadership from the G20 is critically important right now. The global economic situation is as fragile as it has been at any time in the past 50 years. As leaders of the G20, you face a difficult challenge: How do you resolve the immediate crisis while ...
Bill Gates
core
Developing and Distributing Essential Medicines to Poor Countries: The DEFEND Proposal [PDF]
The poorest nations of the world suffer from extreme disease burdens, which go largely untreated because weak incomes and the prevailing system of intellectual property rights fail to provide sufficient incentives to develop new treatments and distribute
Ganslandt, Mattias +2 more
core
Current approaches to malaria vaccines. [PDF]
Curr Opin Microbiol, 2022 Duffy PE.
europepmc +1 more source
B and T cell responses to pre-erythrocytic R21/Matrix-M and blood-stage RH5.1/Matrix-M malaria vaccines in endemic settings. [PDF]
Front ImmunolBundi CK +22 more
europepmc +2 more sources